{"id":579868,"date":"2021-12-21T15:24:01","date_gmt":"2021-12-21T15:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=579868"},"modified":"2021-12-21T15:24:01","modified_gmt":"2021-12-21T15:24:01","slug":"hyperhidrosis-market-industry-size-epidemiology-leading-companies-pipeline-drugs-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hyperhidrosis-market-industry-size-epidemiology-leading-companies-pipeline-drugs-and-competitive-analysis-by-delveinsight_579868.html","title":{"rendered":"Hyperhidrosis Market, Industry Size, Epidemiology, Leading Companies, Pipeline, Drugs and Competitive Analysis by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1640067980.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Hyperhidrosis Market, Industry Size, Epidemiology, Leading Companies, Pipeline, Drugs and Competitive Analysis by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1640067980.jpeg\" alt=\"Hyperhidrosis Market, Industry Size, Epidemiology, Leading Companies, Pipeline, Drugs and Competitive Analysis by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Hyperhidrosis Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong>Hyperhidrosis<\/strong>&nbsp;is the condition of heavy sweating and is categorized into various types based on the localization and the underlying cause. The origin of this condition is not known but hyperactivity of the sympathetic nervous system could be the reason. The treatment of hyperhidrosis is clinically dynamic due to the variety of treatment options available.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s&nbsp;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Hyperhidrosis Market<\/a>&nbsp;Insights, Epidemiology, and Market Forecast-2030<\/strong>&nbsp;report delivers an in-depth understanding of the Hyperhidrosis , historical and forecasted epidemiology as well as the Hyperhidrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some Key facts of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Hyperhidrosis Market<\/a>&nbsp;are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to the survey, titled &ldquo;Epidemiological study and considerations of primary focal hyperhidrosis in Japan: From questionnaire analysis&rdquo; by Fujimoto et al., primary focal hyperhidrosis involving in certain sites, is higher in male than females.<\/li>\n<li>As per another survey titled &ldquo;US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey&rdquo; by Strutton et al., approximately 3% of the US population suffer from hyperhidrosis.<\/li>\n<li>According to a study titled &ldquo;Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis&rdquo; by Gossot et al., in a series of 382 French patients treated with endoscopic thoracic sympathectomy (ETS), more than a quarter had palmar and plantar hyperhidrosis, &gt;50% had palmoplantar and axillary hyperhidrosis, less than 10% had palmoplantar and facial hyperhidrosis, 5% had all areas involved, and 8% had axillary hyperhidrosis only.<\/li>\n<li>As per the article by Hajjar et al., titled, &ldquo;The Quality of Life and Satisfaction Rate of Patients With Upper Limb Hyperhidrosis Before and After Bilateral Endoscopic Thoracic Sympathectomy&rdquo;, hyperhidrosis is a functional disorder identified by excessive sweating and its incidence is approximately 1% in any population.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request For Sample Report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/hyperhidrosis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Hyperhidrosis Market Report<\/a>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Hyperhidrosis , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Hyperhidrosis epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Hyperhidrosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Hyperhidrosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hyperhidrosis market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the Hyperhidrosis Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Allergan<\/li>\n<li>Brickell Biotech<\/li>\n<li>TheraVida<\/li>\n<li>Atacama therapeutics<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request For Sample Report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/hyperhidrosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/hyperhidrosis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the Hyperhidrosis Therapies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>BOTOX<\/li>\n<li>BBI-4000 (Sofpironium bromide)<\/li>\n<li>THVD-102<\/li>\n<li>AT-5214<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Hyperhidrosis<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Hyperhidrosis<\/p>\n<p style=\"text-align: justify;\">4. Hyperhidrosis : Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Hyperhidrosis : Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Hyperhidrosis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Hyperhidrosis Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Hyperhidrosis : Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Hyperhidrosis<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">23. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Delveinsight:&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.<\/p>\n<p style=\"text-align: justify;\">Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform&nbsp;<strong>PharmDelve<\/strong>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=hyperhidrosis-market-industry-size-epidemiology-leading-companies-pipeline-drugs-and-competitive-analysis-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/hyperhidrosis-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=hyperhidrosis-market-industry-size-epidemiology-leading-companies-pipeline-drugs-and-competitive-analysis-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hyperhidrosis Market Hyperhidrosis&nbsp;is the condition of heavy sweating and is categorized into various types based on the localization and the underlying cause. The origin of this condition is not known but hyperactivity of the sympathetic nervous system could be the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/hyperhidrosis-market-industry-size-epidemiology-leading-companies-pipeline-drugs-and-competitive-analysis-by-delveinsight_579868.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,413],"tags":[],"class_list":["post-579868","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/579868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=579868"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/579868\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=579868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=579868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=579868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}